Table of contents
Volume 88, Issue 2
Published online 28 January 2003 (163-333)
Review |
Clinical |
Molecular and Cellular Pathology |
Genetics and Genomics |
Experimental Therapeutics
Minireview
Endothelin-1: a multifunctional molecule in cancer FREE
K Grant, M Loizidou and I Taylor
Br J Cancer 88: 163-166; doi:10.1038/sj.bjc.6700750
Review
Chemotherapy for malignant pleural mesothelioma: past results and recent developments FREE
S Tomek, S Emri, K Krejcy and C Manegold
Br J Cancer 88: 167-174; doi:10.1038/sj.bjc.6600673
Clinical
Temozolomide followed by combined immunotherapy with GM-CSF, low-dose IL2 and IFN
in patients with metastatic melanoma FREE
G C de Gast, D Batchelor, M J Kersten, F A Vyth-Dreese, J Sein, W F van de Kasteele, W J Nooijen, O E Nieweg, M A de Waal and W Boogerd
Br J Cancer 88: 175-180; doi:10.1038/sj.bjc.6600717
Baseline and early lymphopenia predict for the risk of febrile neutropenia after chemotherapy FREE
I Ray-Coquard, C Borg, Th Bachelot, C Sebban, I Philip, G Clapisson, A Le Cesne, P Biron, F Chauvin and J Y Blay for the ELYPSE study group
Br J Cancer 88: 181-186; doi:10.1038/sj.bjc.6600724
Outpatient weekly neoadjuvant chemotherapy followed by radiotherapy for advanced nasopharyngeal carcinoma: high complete response and low toxicity rates FREE
J-C Lin, J-S Jan, C-Y Hsu, R-S Jiang and W-Y Wang
Br J Cancer 88: 187-194; doi:10.1038/sj.bjc.6600716
Percentage of the positive area of bone metastasis is an independent predictor of disease death in advanced prostate cancer FREE
M Noguchi, H Kikuchi, M Ishibashi and S Noda
Br J Cancer 88: 195-201; doi:10.1038/sj.bjc.6600715
Molecular and Cellular Pathology
Interaction between Ku80 protein and a widely used antibody to adenomatous polyposis coli FREE
G T Roberts, M L Davies and J A Wakeman
Br J Cancer 88: 202-205; doi:10.1038/sj.bjc.6600732
Transcriptional impairment of 
-catenin/E-cadherin complex is not associated with -catenin mutations in colorectal carcinomas FREE
G A Garinis, N E Spanakis, P G Menounos, E N Manolis and G Peros
Br J Cancer 88: 206-209; doi:10.1038/sj.bjc.6600706
Aberrant caspase-activated DNase (CAD) transcripts in human hepatoma cells FREE
S Y Hsieh, S F Liaw, S N Lee, P S Hsieh, K H Lin, C M Chu and Y F Liaw
Br J Cancer 88: 210-216; doi:10.1038/sj.bjc.6600695
Methylation status of p14ARF and p16INK4a as detected in pancreatic secretions FREE
B Klump, C J Hsieh, O Nehls, S Dette, K Holzmann, R Kie
lich, M Jung, U Sinn, M Ortner, R Porschen and M Gregor
Br J Cancer 88: 217-222; doi:10.1038/sj.bjc.6600734
Effector CD8+CD45RO-CD27-T cells have signalling defects in patients with squamous cell carcinoma of the head and neck FREE
I Kuss, A D Donnenberg, W Gooding and T L Whiteside
Br J Cancer 88: 223-230; doi:10.1038/sj.bjc.6600694
CD24 is an independent prognostic marker of survival in nonsmall cell lung cancer patients FREE
G Kristiansen, K Schlüns, Y Yongwei, C Denkert, M Dietel and I Petersen
Br J Cancer 88: 231-236; doi:10.1038/sj.bjc.6600702
Vascular endothelial growth factor-D is an independent prognostic factor in epithelial ovarian carcinoma FREE
Y Yokoyama, D S Charnock-Jones, D Licence, A Yanaihara, J M Hastings, C M Holland, M Emoto, M Umemoto, T Sakamoto, S Sato, H Mizunuma and S K Smith
Br J Cancer 88: 237-244; doi:10.1038/sj.bjc.6600701
Prognostic significance of positive peritoneal cytology in endometrial carcinoma confined to the uterus FREE
T Kasamatsu, T Onda, N Katsumata, M Sawada, T Yamada, R Tsunematsu, K Ohmi, Y Sasajima and Y Matsuno
Br J Cancer 88: 245-250; doi:10.1038/sj.bjc.6600698
Immunohistochemical analysis of p53 in vulval intraepithelial neoplasia and vulval squamous cell carcinoma FREE
A N Rosenthal, D Hopster, A Ryan and I J Jacobs
Br J Cancer 88: 251-256; doi:10.1038/sj.bjc.6600677
Minichromosome maintenance (Mcm) proteins, cyclin B1 and D1, phosphohistone H3 and in situ DNA replication for functional analysis of vulval intraepithelial neoplasia FREE
E J Davidson, L S Morris, I S Scott, S M Rushbrook, K Bird, R A Laskey, G E Wilson, H C Kitchener, N Coleman and P L Stern
Br J Cancer 88: 257-262; doi:10.1038/sj.bjc.6600729
Genetics and Genomics
Polymorphism of the insulin gene is associated with increased prostate cancer risk FREE
G Y F Ho, A Melman, S-M Liu, M Li, H Yu, A Negassa, R D Burk, A W Hsing, R Ghavamian and S C Chua Jr
Br J Cancer 88: 263-269; doi:10.1038/sj.bjc.6600747
Analysis of the candidate 8p21 tumour suppressor, BNIP3L, in breast and ovarian cancer FREE
J Lai, J Flanagan, W A Phillips, G Chenevix-Trench and J Arnold
Br J Cancer 88: 270-276; doi:10.1038/sj.bjc.6600674
IGF1 genotype, mean plasma level and breast cancer risk in the Hawaii/Los Angeles multiethnic cohort FREE
K DeLellis, S Ingles, L Kolonel, R McKean-Cowdin, B Henderson, F Stanczyk and N M Probst-Hensch
Br J Cancer 88: 277-282; doi:10.1038/sj.bjc.6600728
Experimental Therapeutics
Foscan® uptake and tissue distribution in relation to photodynamic efficacy FREE
P Cramers, M Ruevekamp, H Oppelaar, O Dalesio, P Baas and F A Stewart
Br J Cancer 88: 283-290; doi:10.1038/sj.bjc.6600682
Intratumour heterogeneity in the uptake of macromolecular therapeutic agents in human melanoma xenografts FREE
B A Graff, Y Kvinnsland, A Skretting and E K Rofstad
Br J Cancer 88: 291-297; doi:10.1038/sj.bjc.6600680
A mechanism of resistance to TRAIL/Apo2L-induced apoptosis of newly established glioma cell line and sensitisation to TRAIL by genotoxic agents FREE
Y Arizono, H Yoshikawa, H Naganuma, Y Hamada, Y Nakajima and K Tasaka
Br J Cancer 88: 298-306; doi:10.1038/sj.bjc.6600666
A novel hypoxia-dependent 2-nitroimidazole KIN-841 inhibits tumour-specific angiogenesis by blocking production of angiogenic factors FREE
M Shimamura, H Nagasawa, H Ashino, Y Yamamoto, T Hazato, Y Uto, H Hori and S Inayama
Br J Cancer 88: 307-313; doi:10.1038/sj.bjc.6600667
Genetics and Genomics
Degree of tumour vascularity correlates with drug accumulation and tumour response upon TNF--based isolated hepatic perfusion FREE
B van Etten, M R de Vries, M G A van IJken, T E Lans, G Guetens, G Ambagtsheer, S T van Tiel, G de Boeck, E A de Bruijn, A M M Eggermont and T L M ten Hagen
Br J Cancer 88: 314-319; doi:10.1038/sj.bjc.6600707
Restored T-cell activation mechanisms in human tumour-infiltrating lymphocytes from melanomas and colorectal carcinomas after exposure to interleukin-2 FREE
F De Paola, R Ridolfi, A Riccobon, E Flamini, F Barzanti, A M Granato, G L Mordenti, L Medri, P Vitali and D Amadori
Br J Cancer 88: 320-326; doi:10.1038/sj.bjc.6600679
Experimental Therapeutics
Expression level of integrin 5 on tumour cells affects the rate of metastasis to the kidney FREE
N Tani, S Higashiyama, N Kawaguchi, J Madarame, I Ota, Y Ito, Y Ohoka, S Shiosaka, Y Takada and N Matsuura
Br J Cancer 88: 327-333; doi:10.1038/sj.bjc.6600710
The published online date indicates the date that the issue is published online and is the first official publication date of the issue. Each print issue of BJC is published one week after it has been published online.
